Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Terminal Growth Assume a low terminal growth of 2% beyond 2030 (conservative given pharmas need to continuously replace revenue - essentially inflation-level perpetual growth)
Mounjaro (tirzepatide) is a dual GLP-1/GIP receptor agonist
Working with a therapist who specializes in weight management helps develop coping strategies that persist after medication stops
Take the lowest effective dose : Starting with the lowest dose that provides relief may help decrease the risk of side effects from interactions
US$ 25.14
US$ 22.19
US$ 22.53
US$ 25.79
US$ 22.99
